Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Transplantation. 2020 Jul;104(7):1413–1418. doi: 10.1097/TP.0000000000002997

Table 3.

Sensitivity analysis including patients with HCC or Cholangiocarcinoma

Peak MELD-Na >15 Peak MELD-Na 15 or less p
N 4993 4726
Total # deaths (%) 2253 (45.1) 736 (15.3) <0.001
Person-Years at risk 10,412 14,060
Rate of death per 100 person-years 21.6 5.2
Cause of death n (%) <0.001
Liver 1698 (75.4) 448 (60.9)
Nonliver 477 (21.2) 264 (35.9)
Nondescript 78 (3.5) 24 (3.3)
Subcategory if Liver Related n (%) <0.001
 Bleeding 47 (2.7) 14 (3.1)
 Infectious 378 (21.7) 89 (19.4)
 Oncologic 352 (20.2) 158 (34.4)
 Other Portal hypertensive 104 (6.0) 27 (5.9)
 Varices 74 (4.2) 17 (3.7)
 Other 787 (45.2) 154 (33.6)